| Ratio of chemokine to G3PDH mRNA copy number | ||
---|---|---|---|
 | (% of no treatment) | ||
 | CCL2/MCP-1 | CXCL1/CINC-1 | CX3CL1/fractalkine |
no treatment | 100.0 ± 31.4 (20) | 100.0 ± 22.0 (20) | 100.0 ± 17.5 (24) |
100 nM ET-1 | 313.8 ± 65.1 (20)a | 404.7 ± 63.9 (20)a | 37.5 ± 8.5 (23)a |
+ 30 μM BAPTA/0.5 mM EGTA | 307.4 ± 89.0 (7) | 342.7 ± 65.0 (7) | 122.8 ± 25.2 (9)b |
+ 10 nM staurosporine | 444.8 ± 122.3 (6) | 385.4 ± 79.0 (6) | 108.6 ± 25.6 (4)b |
+ 100 μM PDTC | 129.2 ± 16.5 (12)b | 140.2 ± 20.7 (12)b | 42.5 ± 8.8 (18) |
+ 10 μM SN50 | 188.7 ± 64.3(8)b | 136.1 ± 22.6 (8)b | 54.6 ± 23.9 (11) |
+ 500 nM mithramycin | 37.8 ± 9.2 (8)c | 49.8 ± 24.1 (8)c | 36.3 ± 11.7 (10) |
+ 50 μM PD98059 | 277.4 ± 90.7 (12) | 360.2 ± 103.2 (12) | 49.6 ± 7.2 (10) |
+ 20 μM SB203580 | 118.3 ± 36.9 (13)c | 229.1 ± 73.6 (13)b | 37.1 ± 6.3 (20) |
+ 1 μM SP600125 | 110.2 ± 23.6 (8)b | 188.5 ± 22.5 (8)b | 47.1 ± 22.0 (10) |